Primary Nocardia brain abscesses and role of intraventricular antibiotic therapy
Por:
Pereira, MR, Cortes, CA
Publicada:
1 sep 2021
Ahead of Print:
1 ago 2021
Resumen:
Intracranial infections caused by Nocardia Farcinica are challenging to treat and potentially lethal because of the organism's tendency to resist antibiotics and high relapse rates. Such infections usually occur in immunocompromised patients who have predisposing factors. Nocardia brain abscesses carry a higher morbidity and mortality rate than other bacterial brain abscesses, with reported mortality rates of 55% (even up to 90% in cases of late diagnosis) in immunocompromised patients. An aggressive therapeutic approach is required and an early identification of the microorganism is paramount. Given the high microbial resistance, it is usually an infection with a low cure rate. We present the case of a patient with primary brain abscesses due to Nocardia Farcinica, successfully treated with intrathecal Amikacin administration through ventricular drain, in addition to surgical evacuation and intravenous antibiotic therapy. In this case, clinical and radiological improvement were observed once the intrathecal treatment was started. To our best knowledge, no cases of intraventricular use of Amikacin have been previously reported to treat this type of infection and we believe that it may be useful in properly selected patients.
Filiaciones:
Pereira, MR:
Hosp Santa Creu & Sant Pau, Dept Neurosurg, Carrer St Quinti 89, Barcelona 08041, Spain
Cortes, CA:
Hosp Santa Creu & Sant Pau, Dept Neurosurg, Carrer St Quinti 89, Barcelona 08041, Spain
|